Atlas

Targa Resources Corp. to Participate in Wolfe Research Utilities, Midstream & Clean Energy Conference

Retrieved on: 
Thursday, September 29, 2022

HOUSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("Targa" or the "Company") announced today that representatives from the Company will participate in investor meetings via video conference at the Wolfe Research Utilities, Midstream & Clean Energy Conference on Friday, September 30, 2022.

Key Points: 
  • HOUSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("Targa" or the "Company") announced today that representatives from the Company will participate in investor meetings via video conference at the Wolfe Research Utilities, Midstream & Clean Energy Conference on Friday, September 30, 2022.
  • A copy of the slides used for the conference meetings will be available in the Investors section of the Company's website at www.targaresources.com, or by going to https://www.targaresources.com/investors/events .
  • Targa Resources Corp. is a leading provider of midstream services and is one of the largest independent midstream infrastructure companies in North America.
  • The Companys assets connect natural gas and NGLs to domestic and international markets with growing demand for cleaner fuels and feedstocks.

Enterprise to Participate in Wolfe Research Utilities, Midstream & Clean Energy Conference

Retrieved on: 
Thursday, September 29, 2022

Enterprise Products Partners L.P. (NYSE: EPD) announced today that it will participate in virtual one-on-one meetings at the Wolfe Research Utilities, Midstream & Clean Energy Conference on Friday, September 30, 2022.

Key Points: 
  • Enterprise Products Partners L.P. (NYSE: EPD) announced today that it will participate in virtual one-on-one meetings at the Wolfe Research Utilities, Midstream & Clean Energy Conference on Friday, September 30, 2022.
  • The latest investor deck of slides, which may be used to facilitate investor meetings, is accessible on the Enterprise website.
  • Enterprise Products Partners L.P. is one of the largest publicly traded partnerships and a leading North American provider of midstream energy services to producers and consumers of natural gas, NGLs, crude oil, refined products and petrochemicals.
  • The partnerships assets include more than 50,000 miles of pipelines; over 260 million barrels of storage capacity for NGLs, crude oil, refined products and petrochemicals; and 14 Bcf of natural gas storage capacity.

Nextech AR Launches Major Upgrades For Its E-commerce SaaS Platform - ARitize Decorator

Retrieved on: 
Thursday, September 29, 2022

(Nextech or the Company) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (AR) experience technologies and 3D model services is pleased to announce it has released major upgrades and features to its SaaS ARitize Decorator product for e-commerce.

Key Points: 
  • (Nextech or the Company) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (AR) experience technologies and 3D model services is pleased to announce it has released major upgrades and features to its SaaS ARitize Decorator product for e-commerce.
  • ARitize Decorator can be seamlessly integrated onto any e-commerce website acting as a software extension to Nextechs ARitize 3D platform..
  • The Decorator works with ARitize 3D to turn those models into experiences by contextualizing their importance in the e-commerce journey.
  • ARitize Decorator is seamlessly integrated and acts as a software extension to Nextechs ARitize 3D platform, which uses revolutionary AI technology to create high-quality 3D models.

Adrestia appoints Will Lewis as Chair, establishes US Operations and appoints new functional leads

Retrieved on: 
Thursday, September 29, 2022

This platform is delivering, and Im thrilled to help make this revolutionary new approach a reality for patients.

Key Points: 
  • This platform is delivering, and Im thrilled to help make this revolutionary new approach a reality for patients.
  • Similarly, both Phil and Jen are seasoned functional specialists who will maximize the impact of our platform and steer our pipeline to the clinic.
  • Adrestia has developed a leading synthetic rescue drug development platform, which has already identified completely new approaches to treating intractable genetic diseases.
  • Adrestia was co-founded by Professor Steve Jackson and the deep technology investment fund Ahren Innovation Capital, which co-led Adrestias Series A financing along with GSK.

Enterprise Makes Annual Sustainability Report Available

Retrieved on: 
Wednesday, September 28, 2022

Enterprise Products Partners L.P. (NYSE: EPD) today announced that the companys 2021-2022 Annual Sustainability Report is now available and can be accessed on the companys website at www.enterpriseproducts.com/safety-sustainability/environmental-social-go... .

Key Points: 
  • Enterprise Products Partners L.P. (NYSE: EPD) today announced that the companys 2021-2022 Annual Sustainability Report is now available and can be accessed on the companys website at www.enterpriseproducts.com/safety-sustainability/environmental-social-go... .
  • The report is also accessible directly at the following link: 2021-2022 Sustainability Report .
  • Enterprise Products Partners L.P. is one of the largest publicly traded partnerships and a leading North American provider of midstream energy services to producers and consumers of natural gas, NGLs, crude oil, refined products and petrochemicals.
  • The partnerships assets include more than 50,000 miles of pipelines; over 260 million barrels of storage capacity for NGLs, crude oil, refined products and petrochemicals; and 14 billion cubic feet of natural gas storage capacity.

Flight Path Museum LAX relaunches popular simulator classes

Retrieved on: 
Wednesday, September 28, 2022

LOS ANGELES, Sept. 28, 2022 /PRNewswire-PRWeb/ -- Flight Path Museum LAX and its sponsorship partners proudly announce the relaunch of the popular Flight Path Flyers program, an introduction to flight training taught by commercial airline pilots. The classes allow youth to explore the first steps toward a potential aviation career.

Key Points: 
  • Flight Path Museum LAX announces the relaunch of the popular Flight Path Flyers program for high school and college students that offers an introduction to flight training taught by commercial airline pilots.
  • LOS ANGELES, Sept. 28, 2022 /PRNewswire-PRWeb/ -- Flight Path Museum LAX and its sponsorship partners proudly announce the relaunch of the popular Flight Path Flyers program, an introduction to flight training taught by commercial airline pilots.
  • Supported by American Legion Post 283, the Westchester Woman's Club and other generous benefactors, Flight Path has purchased new computer systems specifically designed for flight training.
  • "All high school and undergraduate college students are invited to apply," said Agnes Huff, PhD, Flight Path Museum president.

Tumbleweed Midstream Formally Ends Sales Process of Ladder Creek Helium Plant and Gathering System

Retrieved on: 
Wednesday, September 28, 2022

Tumbleweed Midstream, LLC (Tumbleweed) announced today it has formally ended the sales process of its Ladder Creek Helium Plant and Gathering System.

Key Points: 
  • Tumbleweed Midstream, LLC (Tumbleweed) announced today it has formally ended the sales process of its Ladder Creek Helium Plant and Gathering System.
  • The Ladder Creek Helium Plant and Gathering System serve natural gas producers operating in the helium-rich region of eastern Colorado and western Kansas.
  • Located in Cheyenne County, Colorado, the Ladder Creek Helium Plant uses state-of-the-art cryogenic processes to extract helium and natural gas liquids from raw natural gas.
  • The companys operations are centered at the Ladder Creek Helium Plant and Gathering System located near Cheyenne Wells, Colorado, just west of the Kansas-Colorado border.

Author Russell Hasan is Pleased to Announce the Launch of "Russell's Twenty Book Challenge," An Initiative to Encourage People to Read All Twenty of His Nonfiction Books, and to Thereby Gain Mastery of His Theory of Philosophy, Logic, Economics, Law, Psyc

Retrieved on: 
Wednesday, September 28, 2022

The Challenge is open to everyone and no purchase is necessary to enter.

Key Points: 
  • The Challenge is open to everyone and no purchase is necessary to enter.
  • After a person completes the challenge, they are invited to email a confirmation to Russell Hasan at [email protected] , and he will email them a personalized certificate of completion.
  • Everything is Something: A Philosophical Dialogue About Logic, Language, Words, Meanings, Truth, and The Theory of Things
    5.
  • Love Without Labels: The Fifteen Questions and Answers that Define Your Gender Identity, Sexual Orientation, and Relationship Status
    20.

Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics

Retrieved on: 
Wednesday, September 28, 2022

Financing led by Brandon Capital from its newly established UK operation; Forbion and Atlas Venture co-led the round

Key Points: 
  • Financing led by Brandon Capital from its newly established UK operation; Forbion and Atlas Venture co-led the round
    Investment signals Brandon Capital growth in the UK and Europe, from its HQ in Australia
    MELBOURNE, Australia and LONDON, Sept. 28, 2022 /PRNewswire/ -- Brandon Capital, Australasia's leading life science venture capital firm, is pleased to announce its leading role in the USD68m series A financing of Pheon Therapeutics (Pheon), that has emerged from stealth today.
  • The Pheon financing reflects Brandon Capital's ongoing growth and signals its goal to become an active international investor including in the UK and European markets.
  • Pheon is an emerging UK-based Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.
  • It has recently signed a collaboration with an Australian research member of the Brandon Capital managed Brandon BioCatalyst a unique network of over 50 leading medical research institutes.

Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics

Retrieved on: 
Wednesday, September 28, 2022

Financing led by Brandon Capital from its newly established UK operation; Forbion and Atlas Venture co-led the round

Key Points: 
  • Financing led by Brandon Capital from its newly established UK operation; Forbion and Atlas Venture co-led the round
    Investment signals Brandon Capital growth in the UK and Europe, from its HQ in Australia
    MELBOURNE, Australia and LONDON, Sept. 28, 2022 /PRNewswire/ -- Brandon Capital, Australasia's leading life science venture capital firm, is pleased to announce its leading role in the USD68m series A financing of Pheon Therapeutics (Pheon), that has emerged from stealth today.
  • The Pheon financing reflects Brandon Capital's ongoing growth and signals its goal to become an active international investor including in the UK and European markets.
  • Pheon is an emerging UK-based Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.
  • It has recently signed a collaboration with an Australian research member of the Brandon Capital managed Brandon BioCatalyst a unique network of over 50 leading medical research institutes.